{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:14:02Z","timestamp":1790399642717,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish MNiSW","award":["N N401 006635"],"award-info":[{"award-number":["N N401 006635"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neuint.2013.09.021","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T13:14:28Z","timestamp":1380546868000},"page":"790-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA"],"prefix":"10.1016","volume":"63","author":[{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Konieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2013.09.021_b0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(94)90298-4","article-title":"Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine","volume":"666","author":"Abekawa","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2013.09.021_b0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(94)91511-3","article-title":"Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase","volume":"667","author":"Arai","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-8993(03)02555-1","article-title":"Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod","volume":"973","author":"Bergquist","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0028-3908(94)90037-X","article-title":"The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro","volume":"33","author":"Black","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02260966","article-title":"NADPH-diaphorase\/nitric oxide synthase containing neurons in normal and Parkinson\u2019s disease putamen","volume":"7","author":"B\u00f6ckelmann","year":"1994","journal-title":"J. Neural. Transm. Park Dis. Dement Sect."},{"key":"10.1016\/j.neuint.2013.09.021_b0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/cvr\/28.4.494","article-title":"Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats","volume":"28","author":"B\u00f6ger","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1472-8206.1997.tb00857.x","article-title":"Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate","volume":"11","author":"B\u00fcy\u00fckuysal","year":"1997","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0014-2999(93)90118-2","article-title":"Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice","volume":"231","author":"Calignano","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(91)91399-L","article-title":"Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance","volume":"568","author":"Carey","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(01)00231-7","article-title":"Coadministration of L-NOARG and tiapride: effects on catalepsy in male mice","volume":"26","author":"Cavas","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.09.021_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/71090","article-title":"Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation","volume":"3","author":"Choi","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/REVNEURO.1997.8.1.55","article-title":"The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra","volume":"8","author":"Crocker","year":"1997","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10571-005-3065-8","article-title":"Role of nitric oxide on motor behavior","volume":"25","author":"Del Bel","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2013.09.021_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0306-3623(97)00075-X","article-title":"Catalepsy induced by nitric oxide synthase inhibitors","volume":"30","author":"Del Bel","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0893-133X(95)00153-5","article-title":"7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice","volume":"15","author":"Deutsch","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1460-9568.2000.00927.x","article-title":"NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis","volume":"12","author":"de Vente","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.2008.03678.x","article-title":"Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study","volume":"1155","author":"Di Matteo","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2013.09.021_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-4328(97)02281-X","article-title":"New and potent inhibitors of nitric oxide synthase reduce motor activity in mice","volume":"87","author":"Dzoljic","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0169-328X(98)00259-9","article-title":"Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson\u2019s disease","volume":"63","author":"Eve","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.expneurol.2013.03.002","article-title":"Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons","volume":"247","author":"Frau","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.09.021_b0120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","article-title":"Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms","volume":"28","author":"Giorgi","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(79)90283-8","article-title":"Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons","volume":"59","author":"Grace","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(85)91581-1","article-title":"Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity","volume":"333","author":"Grace","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain","volume":"76","author":"Guix","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2013.09.021_b0140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1471-4159.1994.62020807.x","article-title":"Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP","volume":"62","author":"Guevara-Guzman","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1037\/1064-1297.16.2.178","article-title":"7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson\u2019s disease","volume":"16","author":"Haik","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.09.021_b0155","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2013.09.021_b0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-009-1687-0","article-title":"Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity","volume":"207","author":"Hoque","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0170","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1046\/j.1471-4159.1998.71051969.x","article-title":"Differential release of dopamine by nitric oxide in subregions of rat caudate putamen slices","volume":"71","author":"Iravani","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4522(01)00562-0","article-title":"Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration","volume":"110","author":"Iravani","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2013.09.021_b0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)03147-X","article-title":"MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats","volume":"926","author":"Jonkers","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0896-6273(00)80859-4","article-title":"Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO\u2013","volume":"24","author":"Kim","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2013.09.021_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2013.09.021_b0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-2236(00)01745-8","article-title":"Nitric oxide: a novel link between synaptic and nonsynaptic transmission","volume":"24","author":"Kiss","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuint.2003.11.004","article-title":"Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors","volume":"45","author":"Kiss","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2013.09.021_b0210","first-page":"263","article-title":"Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism?","volume":"49","author":"Krz\u0105\u015bcik","year":"1997","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0022-510X(94)90155-4","article-title":"Decreased cerebrospinal fluid nitrate levels in Parkinson\u2019s disease, Alzheimer\u2019s disease and multiple system atrophy patients","volume":"121","author":"Kuiper","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2013.09.021_b0220","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neuroscience.2008.10.019","article-title":"Nitric oxide-cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: cell type-specific regulation of heme oxygenase-1 expression","volume":"158","author":"Kurauchi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2013.09.021_b0225","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.expneurol.2005.06.006","article-title":"Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson\u2019s disease?","volume":"197","author":"Lane","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.09.021_b0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(98)00452-1","article-title":"The regulation of dopamine release from striatum slices by tetrahydrobiopterin and L-arginine-derived nitric oxide","volume":"800","author":"Liang","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0235","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2006.09.019","article-title":"The \u201cmotor complication syndrome\u201d in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration","volume":"177","author":"Lindgren","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0240","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2013.09.021_b0245","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jnr.490350210","article-title":"Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices","volume":"35","author":"Lonart","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF03348006","article-title":"Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man","volume":"20","author":"Maccario","year":"1997","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.neuint.2013.09.021_b0255","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2013.09.021_b0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0014-2999(94)90790-0","article-title":"Endogenous nitric oxide modulates behavioural effects elicited by substance P in rat","volume":"271","author":"Mancuso","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0265","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.1993.tb03580.x","article-title":"Nitric oxide synthase activity endogenously modulates NMDA receptors","volume":"61","author":"Manzoni","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0896-6273(92)90087-T","article-title":"Nitric oxide-induced blockade of NMDA receptors","volume":"8","author":"Manzoni","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2013.09.021_b0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00001756-199512000-00038","article-title":"L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice","volume":"7","author":"Marras","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2013.09.021_b0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-8993(00)02254-X","article-title":"Nitric oxide donor-induced increase in permeability of the blood-brain barrier","volume":"866","author":"Mayhan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(97)01428-3","article-title":"Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine","volume":"341","author":"Meyer","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0290","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1523\/JNEUROSCI.3696-05.2006","article-title":"Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation","volume":"26","author":"Min","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson\u2019s disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2013.09.021_b0300","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson\u2019s disease","volume":"41","author":"Navailles","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2013.09.021_b0305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(94)00742-P","article-title":"Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice","volume":"275","author":"Ohno","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroscience.2009.01.034","article-title":"Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson\u2019s disease","volume":"159","author":"Padovan-Neto","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2013.09.021_b0315","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1471-4159.2009.06416.x","article-title":"Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions","volume":"111","author":"Park","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0320","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuint.2013.09.021_b0325","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awq342","article-title":"Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia","volume":"134","author":"Picconi","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2013.09.021_b0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(01)01164-5","article-title":"Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat","volume":"426","author":"Pitsikas","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0335","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-002-1090-6","article-title":"Effects of the nitric oxide donor molsidomine on different memory components as assessed in the object-recognition task in the rat","volume":"162","author":"Pitsikas","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0340","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0306-4522(03)00067-8","article-title":"The GABAB receptor and recognition memory: possible modulation of its behavioral effects by the nitrergic system","volume":"118","author":"Pitsikas","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2013.09.021_b0345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neurobiolaging.2004.04.003","article-title":"The nitric oxide donor molsidomine antagonizes age-related memory deficits in the rat","volume":"26","author":"Pitsikas","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2013.09.021_b0350","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.20889","article-title":"Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801","volume":"84","author":"Pitsikas","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0355","first-page":"291","article-title":"Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats","volume":"49","author":"Przegali\u0144ski","year":"1997","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0360","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0024-3205(93)90559-L","article-title":"L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine","volume":"53","author":"Pudiak","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2013.09.021_b0365","first-page":"282","article-title":"Molsidomine","volume":"27","author":"Reden","year":"1990","journal-title":"Blood Vessels"},{"key":"10.1016\/j.neuint.2013.09.021_b0370","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.09-09-03326.1989","article-title":"Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms","volume":"9","author":"Robertson","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0375","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(89)91689-2","article-title":"D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour","volume":"503","author":"Robertson","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0380","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2165\/00003088-199630050-00004","article-title":"Clinical pharmacokinetics of molsidomine","volume":"30","author":"Rosenkranz","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuint.2013.09.021_b0385","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.npp.1300826","article-title":"Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1\/5) receptor-dependent mechanism","volume":"31","author":"Sammut","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0390","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00213-006-0681-z","article-title":"Dopamine D2 receptor-dependent modulation of striatal NO synthase activity","volume":"191","author":"Sammut","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0395","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","article-title":"Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation","volume":"20","author":"Sancesario","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(95)00068-V","article-title":"Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats","volume":"277","author":"Sandi","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0410","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0415","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1471-4159.2003.01929.x","article-title":"Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin","volume":"86","author":"Shibata","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/135100005X38842","article-title":"Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson\u2019s disease","volume":"10","author":"Singh","year":"2005","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuint.2013.09.021_b0425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(94)00644-M","article-title":"Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?","volume":"272","author":"Starr","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.09.021_b0430","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(94)91827-9","article-title":"Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine","volume":"641","author":"Stewart","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0435","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1471-4159.1996.66010131.x","article-title":"Evidence that nitric oxide causes calcium-independent release of [3H] dopamine from rat striatum in vitro","volume":"66","author":"Stewart","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0440","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2013.09.021_b0445","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-2396(199608)23:4<280::AID-SYN6>3.0.CO;2-3","article-title":"Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects","volume":"23","author":"Timmerman","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2013.09.021_b0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s002130100708","article-title":"Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat","volume":"156","author":"Trevitt","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0455","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s002130100908","article-title":"Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies","volume":"159","author":"Trevitt","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.neuint.2013.09.021_b0465","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-007-9080-3","article-title":"Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson\u2019s disease","volume":"23","author":"Watanabe","year":"2008","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2013.09.021_b0470","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1046\/j.1471-4159.1996.66051971.x","article-title":"Intrastriatal infusion of (+\/\u2212)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats","volume":"66","author":"West","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.09.021_b0475","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0028-3908(97)00148-2","article-title":"Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms","volume":"36","author":"West","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0480","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0197-0186(98)00054-0","article-title":"Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms","volume":"33","author":"West","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2013.09.021_b0485","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/syn.10076","article-title":"Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms","volume":"44","author":"West","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2013.09.021_b0490","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1152\/jn.2000.83.4.1796","article-title":"Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo","volume":"83","author":"West","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuint.2013.09.021_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsys.2011.00055","article-title":"Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson\u2019s disease?","volume":"5","author":"West","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuint.2013.09.021_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2007.05.002","article-title":"Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats","volume":"59","author":"Yamada","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuint.2013.09.021_b0505","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neuropharm.2012.07.031","article-title":"7-Nitroindazole down-regulates dopamine\/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson\u2019s disease","volume":"63","author":"Yuste","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2013.09.021_b0510","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.1992.tb08332.x","article-title":"Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices","volume":"59","author":"Zhu","year":"1992","journal-title":"J. Neurochem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:24:10Z","timestamp":1564187050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018613002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0197018613002490"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2013.09.021","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2013.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}